
CONTINUUS Pharmaceuticals: A one-stop solution for pharmaceutical manufacturing, leveraging novel ICM technology.
Founded with a mission to revolutionize pharmaceutical manufacturing, CONTINUUS Pharmaceuticals offers a comprehensive "one-shop solution" for the entire development and manufacturing cycle of small molecule drugs. Utilizing their pioneering Integrated Continuous Manufacturing (ICM) platform, CONTINUUS works directly with pharmaceutical and generic companies under a Build-Own-Operate model. This approach ensures streamlined, efficient, and cost-effective production processes, addressing various client-specific needs across the supply chain.
Notable affiliated individuals include experts in pharmaceutical engineering and continuous manufacturing, who have significantly contributed to the development of the ICM technology. The company has achieved key milestones, including successful collaborations with leading pharmaceutical firms and securing substantial funding for research and development. CONTINUUS Pharmaceuticals' innovative solutions have made a significant impact on the industry by enhancing production efficiency, reducing costs, and ensuring consistent product quality.
Companies similar to Continuus Pharmaceuticals include Continuity Pharma, Selkirk Pharma, Societal Cdmo and Bright Path Laboratories.
Continuus Pharmaceuticals was founded in 2012.
Continuus Pharmaceuticals' headquarters is located in Woburn, MA, US.
Continuus Pharmaceuticals' most recent funding round was for $5M (USD) in September 2019.
As of Sep 5, 2019, Continuus Pharmaceuticals has disclosed funding of $9.1M (USD). Undisclosed round amounts are excluded.
Continuus Pharmaceuticals has 49 employees as of Feb 5, 2024.
Bright Path Laboratories
brightpath.inc